Clinical Trial Update: The Use of Photobiomodulation in the Treatment of Oral Complaints of Long COVID-19.A Randomized Controlled Trial. [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating photobiomodulation for oral complaints in long COVID includes xerostomia and persistent COVID-19 symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Persistent COVID-19
• Xerostomia

Snippet

Sponsor: University of Nove de Julho | Conditions: Xerostomia, COVID-19 | Phase 2 | Status: COMPLETED